Skip to content
healthcare.dev

Mucus Relief

NDC 0615-8637, Guaifenesin, tablet, extended release, from NCS HealthCare of KY, LLC dba Vangard Labs.

Product NDC
0615-8637
Status
Listed
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209215
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8637 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
0615-8637-390061586373930 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8637-39)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0615-8637 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8637 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0615-8637. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.